Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CMD Cantel Medical	$80.37	$82.48	$39.40 ▼ $89.76	$3.58B	1.55	626,604 shs	N/A
GKOS Glaukos	$103.68 -2.7%	$97.18	$77.10 ▼ $163.71	$6.09B	0.82	742,471 shs	660,520 shs
ICUI ICU Medical	$132.16 -3.7%	$133.70	$117.92 ▼ $196.26	$3.38B	0.87	259,275 shs	140,620 shs
NARI Inari Medical	$79.97	$79.97	$39.76 ▼ $79.99	$4.68B	1.02	1.46 million shs	N/A
NUVA NuVasive	$39.75	$39.64	$35.17 ▼ $49.53	$2.08B	1.07	1.16 million shs	N/A

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CMD Cantel Medical	0.00%	0.00%	0.00%	0.00%	0.00%
GKOS Glaukos	+1.53%	+3.04%	+11.47%	+18.44%	-11.22%
ICUI ICU Medical	+1.13%	+1.30%	+0.34%	-3.78%	+11.59%
NARI Inari Medical	0.00%	0.00%	0.00%	0.00%	+54.74%
NUVA NuVasive	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CMD Cantel Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GKOS Glaukos	4.3771 of 5 stars	4.4	1.0	0.0	4.4	2.4	1.7	0.6
ICUI ICU Medical	4.5627 of 5 stars	3.5	2.0	0.0	3.9	2.5	2.5	1.9
NARI Inari Medical	0.3432 of 5 stars	1.1	0.0	0.0	0.0	0.0	2.5	0.6
NUVA NuVasive	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CMD Cantel Medical	0.00	N/A	N/A	N/A
GKOS Glaukos	2.75	Moderate Buy	$134.67	29.89% Upside
ICUI ICU Medical	3.00	Buy	$192.67	45.78% Upside
NARI Inari Medical	2.14	Hold	$69.22	-13.44% Downside
NUVA NuVasive	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest ICUI, GKOS, NARI, CMD, and NUVA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/9/2025	ICUI ICU Medical	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Strong-Buy ➝ Strong-Buy	$197.00 ➝ $187.00
5/6/2025	GKOS Glaukos	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$110.00 ➝ $72.00
5/2/2025	GKOS Glaukos	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$140.00 ➝ $115.00
5/1/2025	GKOS Glaukos	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$140.00 ➝ $135.00
5/1/2025	GKOS Glaukos	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$140.00 ➝ $115.00
5/1/2025	GKOS Glaukos	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$176.00 ➝ $115.00
5/1/2025	GKOS Glaukos	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$160.00 ➝ $86.00
4/21/2025	ICUI ICU Medical	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$209.00 ➝ $191.00
4/16/2025	GKOS Glaukos	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$200.00 ➝ $175.00
4/15/2025	GKOS Glaukos	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$180.00 ➝ $165.00
4/11/2025	GKOS Glaukos	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$185.00 ➝ $140.00

(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CMD Cantel Medical	$1.02B	3.52	$3.38 per share	23.78	$17.31 per share	4.64
GKOS Glaukos	$383.48M	15.45	N/A	N/A	$13.91 per share	7.45
ICUI ICU Medical	$2.38B	1.37	$13.50 per share	9.79	$80.26 per share	1.65
NARI Inari Medical	$493.63M	9.48	$0.09 per share	906.95	$8.07 per share	9.91
NUVA NuVasive	$1.23B	1.70	$4.96 per share	8.01	$17.02 per share	2.34

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CMD Cantel Medical	$13.71M	$1.65	69.28	28.91	1.63	4.72%	12.13%	4.45%	N/A
GKOS Glaukos	-$146.37M	-$2.37	N/A	N/A	N/A	-31.40%	-10.66%	-8.06%	7/30/2025 (Estimated)
ICUI ICU Medical	-$117.69M	-$3.83	N/A	24.29	N/A	-3.87%	6.75%	3.20%	8/6/2025 (Estimated)
NARI Inari Medical	-$1.64M	-$1.35	N/A	727.00	N/A	-13.68%	-10.09%	-6.60%	N/A
NUVA NuVasive	$40.41M	$0.50	79.50	15.35	N/A	2.32%	12.17%	4.88%	N/A

Latest ICUI, GKOS, NARI, CMD, and NUVA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	ICUI ICU Medical	$1.44	N/A	N/A	N/A	$543.33 million	N/A
7/30/2025	Q2 2025	GKOS Glaukos	-$0.26	N/A	N/A	N/A	$115.49 million	N/A
5/8/2025	Q1 2025	ICUI ICU Medical	$1.23	$1.72	+$0.49	-$0.63	$574.15 million	$599.49 million
4/30/2025	Q1 2025	GKOS Glaukos	-$0.33	-$0.22	+$0.11	-$0.32	$102.78 million	$106.66 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CMD Cantel Medical	$0.21	0.26%	N/A	12.73%	N/A
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
ICUI ICU Medical	N/A	N/A	N/A	N/A	N/A
NARI Inari Medical	N/A	N/A	N/A	N/A	N/A
NUVA NuVasive	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CMD Cantel Medical	1.16	2.72	2.00
GKOS Glaukos	0.09	6.49	5.62
ICUI ICU Medical	0.75	2.59	1.52
NARI Inari Medical	N/A	1.77	1.40
NUVA NuVasive	0.50	1.25	0.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CMD Cantel Medical	84.13%
GKOS Glaukos	99.04%
ICUI ICU Medical	96.10%
NARI Inari Medical	90.98%
NUVA NuVasive	N/A

Insider Ownership

Company	Insider Ownership
CMD Cantel Medical	10.70%
GKOS Glaukos	5.80%
ICUI ICU Medical	1.50%
NARI Inari Medical	10.60%
NUVA NuVasive	0.53%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CMD Cantel Medical	3,669	44.51 million	N/A	Optionable
GKOS Glaukos	780	57.14 million	53.83 million	Optionable
ICUI ICU Medical	15,000	24.61 million	24.24 million	Optionable
NARI Inari Medical	800	58.54 million	52.34 million	Optionable
NUVA NuVasive	3,000	52.45 million	52.17 million	Optionable

ICUI, GKOS, NARI, CMD, and NUVA Headlines

Recent News About These Companies

The 5 Most Interesting Analyst Questions From Globus Medical’s Q1 Earnings Call

July 1, 2025 | msn.com

Analysts downgrade Globus Medical on fears of ‘foundational cracks’

May 27, 2025 | massdevice.com

BTIG Downgrades Globus Medical (GMED) to Neutral on Spine Business Concerns

May 27, 2025 | msn.com

Globus Medical Q1 sales dip slightly: 5 notes

May 10, 2025 | beckersspine.comB

Verdict Against NuVasive in Patent Dispute

May 9, 2025 | ryortho.comR

5 patent battles to know

May 2, 2025 | beckersasc.comB

NuVasive infringed surgeon’s spine patents, jury says

April 24, 2025 | beckersspine.comB

Artificial Tendons and Ligaments Market Expected to Hit USD 2.7 Billion by 2035 with a Remarkable 10.46% CAGR

April 23, 2025 | biznes.newseria.plB

NuVasive Infringes Surgeon’s Spinal-Screws Patents, Jury Says

April 22, 2025 | news.bloomberglaw.comN

Spine company names Keith Valentine CEO

April 11, 2025 | beckersspine.comB

The Perils of Procedural Misadventure and Unclear Claim Drafting in Patent Litigation

March 26, 2025 | jdsupra.com

Global Medical Handily Beats 2024 Sales Estimates

March 14, 2025 | ryortho.comR

Globus Medical targets $2.8B-$2.9B revenue in 2025 with Nevro acquisition integration

February 21, 2025 | msn.com

Globus Medical Q4, 2024 sales rise

February 20, 2025 | beckersspine.comB

Globus Medical: Some Caution After Its Deal For Nevro

February 16, 2025 | seekingalpha.com

Florida Sales Rep Ordered to Pay $19 million

February 10, 2025 | ryortho.comR

BTIG maintains $91 target on Globus Medical stock post-acquisition

February 6, 2025 | msn.com

Globus acquisition of Nevro complicates story, says Stifel

February 6, 2025 | markets.businessinsider.com

SMAIO Provides Update on Its Partnership With NuVasive and Confirms Its Strategic Focus on the U.S. Market

January 27, 2025 | uk.finance.yahoo.com

NuVasive, SMAIO end orthopedic partnership

January 27, 2025 | beckersspine.comB

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICUI, GKOS, NARI, CMD, and NUVA Company Descriptions

Cantel Medical NYSE:CMD

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Glaukos NYSE:GKOS

$103.68 -2.87 (-2.69%)

Closing price 03:59 PM Eastern

Extended Trading

$103.81 +0.13 (+0.12%)

As of 05:48 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

ICU Medical NASDAQ:ICUI

$132.16 -5.10 (-3.72%)

Closing price 04:00 PM Eastern

Extended Trading

$132.22 +0.06 (+0.04%)

As of 05:23 PM Eastern

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Inari Medical NASDAQ:NARI

$79.97 0.00 (0.00%)

As of 02/19/2025

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

NuVasive NASDAQ:NUVA

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time